Table 1– Description of subjects by sex and chronic obstructive pulmonary disease (COPD) status
VariablesFemaleMale
COPDNo COPDCOPDNo COPD
Subjects36228503971705
Age yrs64.8±0.7#55.4±0.2¶¶63.5±0.6#54.3±0.3
BMI kg·m−227.2±0.3#,¶28.8±0.1++26.5±0.2+27.4±0.1
BMI categories
 Underweight29 (8.0)#,¶79 (2.8)++22 (5.5)+56 (3.3)
 Normal100 (27.6)693 (24.3)130 (32.8)423 (24.8)
 Overweight135 (37.3)1066 (37.4)168 (42.3)807 (47.3)
 Obese98 (27.1)1012 (35.5)77 (19.4)419 (24.6)
White subjects236 (65.2)+1526 (53.8)§§253 (63.7)863 (50.8)
Education yrs6.5±0.3+7.5±0.1++6.8±0.3#8.1±0.2
Employed112 (30.9)#,§1303 (45.7)++205 (51.6)#1299 (76.2)
Smoking exposure pack-yrs11.6±1.2#,§6.0±0.3++26.5±1.4#14.1±0.5
Smoking status
 Current113 (31.2)ƒ,§706 (24.8)++160 (40.3)+604 (35.5)
 Former75 (20.7)603 (21.2)172 (43.3)617 (36.3)
 Never174 (48.1)1541 (54.1)65 (16.4)481 (28.3)
Cough118 (32.6)#582 (20.4)§§120 (30.2)#288 (16.9)
Phlegm97 (26.8)#471 (16.5)118 (29.7)#308 (18,1)
Wheezing142 (39.2)#620 (21.8)153 (38.5)#353 (20.7)
Dyspnoea214 (60.5)##,§1469 (52.0)++165 (41.9)##561 (33.3)
Self-reported tuberculosis19 (5.3)+66 (2.3)§§20 (5.0)#22 (1.3)
Comorbidity score1.35±0.05#,§1.10±0.02++1.01±0.05+0.79±0.02
Any respiratory medication69 (19.1)#,¶172 (6.0)++44 (11.1)#55 (3.2)
Any bronchodilator64 (17.7)#,¶158 (5.5)++43 (10.8)#47 (2.8)
Any corticosteroid25 (6.9)#45 (1.6)§§17 (4.3)#15 (0.9)
Prior spirometry68 (18.8)#239 (8.4)++84 (21.2)#212 (12.5)
  • Data are presented as n, mean±se and n (%). Statistical tests used were as follows: for nominal variables, Pearson Chi-squared adjusted for survey design; for ordinal variables, Mann–Whitney test and ordered logistic regression adjusted for survey design (p-values reflect Mann–Whitney test); for continuous variables, Wald test adjusted for survey design. BMI: body mass index. #: p<0.0001 (COPD versus no COPD); : p<0.05 (COPD female versus COPD male); +: p<0.001 (COPD versus no COPD); §: p<0.001 (COPD female versus COPD male); ƒ: p<0.05 (COPD versus no COPD); ##: p<0.01 (COPD versus no COPD); ¶¶: p<0.001 (no COPD female versus no COPD male); ++: p<0.0001 (no COPD female versus no COPD male); §§: p<0.05 (no COPD female versus no COPD male).